Role of Triggering Receptor Expressed on Myeloid Cells (TREM-1) as a Novel Biomarker in Human Epidermal Growth Factor Receptor -2 (HER-2) Negative Breast Cancer: a Molecular and Clinical Study
Not yet recruitingOBSERVATIONAL
Enrollment
1
Participants
Timeline
Start Date
September 15, 2025
Primary Completion Date
September 15, 2028
Study Completion Date
September 30, 2029
Conditions
Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIBreast Cancer Invasive